The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 20, 2019
Filed:
Jun. 15, 2017
Applicant:
Gilead Sciences, Inc., Foster Ctiy, CA (US);
Inventors:
Ernest A. Carra, Foster City, CA (US);
Irene Chen, San Mateo, CA (US);
Vahid Zia, Palo Alto, CA (US);
Assignee:
Gilead Sciences, Inc., Foster City, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/18 (2006.01); A61K 31/553 (2006.01); A61K 31/675 (2006.01); A61K 31/513 (2006.01); C07D 498/14 (2006.01); A61K 9/20 (2006.01); A61K 31/537 (2006.01); A61K 31/685 (2006.01); A61K 45/06 (2006.01); A61K 31/683 (2006.01);
U.S. Cl.
CPC ...
C07D 498/18 (2013.01); A61K 9/20 (2013.01); A61K 9/2054 (2013.01); A61K 31/513 (2013.01); A61K 31/537 (2013.01); A61K 31/553 (2013.01); A61K 31/675 (2013.01); A61K 31/683 (2013.01); A61K 31/685 (2013.01); A61K 45/06 (2013.01); C07D 498/14 (2013.01); C07B 2200/13 (2013.01);
Abstract
The present invention relates to sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2′:4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate Form I, pharmaceutical formulations, and uses thereof for treating or prophylactically preventing an HIV infection.